C/EBPα is a DNA damage-inducible p53-regulated mediator of the G 1 checkpoint in keratinocytes

Molecular and Cellular Biology

Volumn 24, Issue 24, 2004, Pages 10650-10660

  Yoon, Kyungsil ^a   Smart, Robert C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIA TELANGIECTASIA MUTATED KINASE; ATM PROTEIN; BLEOMYCIN; CAFFEINE; CCAAT ENHANCER BINDING PROTEIN ALPHA; DNA; ETOPOSIDE; LEUCINE ZIPPER PROTEIN; MESSENGER RNA; METHYLNITRONITROSOGUANIDINE; PROTEIN KINASE; PROTEIN P53; RAD3 RELATED KINASE; UNCLASSIFIED DRUG; CASPASE; MUTAGENIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL MUTANT; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; SKIN CANCER; TRANSCRIPTION REGULATION; ULTRAVIOLET B RADIATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; CELL STRAIN 3T3; DRUG EFFECT; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENETICS; IMMUNOHISTOCHEMISTRY; KINETICS; METABOLISM; MOUSE STRAIN; PATHOLOGY; RADIATION EXPOSURE; RADIATION RESPONSE; RAT; RETROVIRUS; SERODIAGNOSIS; SKIN; TIME; ULTRAVIOLET RADIATION; WESTERN BLOTTING;

ANIMALIA;

ANIMALS; BLOTTING, WESTERN; CASPASES; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE; CELLS, CULTURED; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FIBROBLASTS; G1 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; KINETICS; METHYLNITRONITROSOGUANIDINE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MUTAGENS; NIH 3T3 CELLS; PRECIPITIN TESTS; RATS; RETROVIRIDAE; SKIN; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 10044222111     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.24.10650-10660.2004     Document Type: Article

References (63)

1. Antonson, P., and K. G. Xanthopoulos. 1995. Molecular cloning, sequence, and expression patterns of the human gene encoding CCAAT/enhancer binding protein alpha (C/EBP alpha). Biochem. Biophys. Res. Commun. 215:106-113.
2. Appella, E., and C. W. Anderson. 2001. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268:2764-2772.
3. Berg, R. J., H. J. van Kranen, H. G. Rebel, A. de Vries, W. A. van Vloten, C. F. Van Kreijl, J. C. van der Leun, and F. R. de Gruijl. 1996. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc. Natl. Acad. Sci. USA 93:274-278.
4. Birkenmeier, E. H., B. Gwynn, S. Howard, J. Jerry, J. I. Gordon, W. H. Landschulz, and S. L. McKinght. 1989. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/ enhancer binding protein. Genes Dev. 3:1146-1156.
5. Bissonnette, N., and D. J. Hunting. 1998. p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene 16:3461-3469.
6. Brash, D. E. 1997. Sunlight and the onset of skin cancer. Trends Genet. 13:410-414.
7. Brash, D. E., J. A. Rudolph, J. A. Simon, A. Lin, G. J. McKenna, H. P. Baden, A. J. Halperin, and J. Ponten. 1991. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 88:10124-10128.
8. 2/M checkpoint. Genes Dev. 14:1584-1588.
9. Chao, C., M. Hergenhahn, M. D. Kaeser, Z. Wu, S. Saito, R. Iggo, M. Hollstein, E. Appella, and Y. Xu. 2003. Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses. J. Biol. Chem. 278:41028-41033.
10. de Gruijl, F. R., H. J. van Kranen, and L. H. Mullenders. 2001. UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J. Photochem. Photobiol. B 63:19-27.
11. Diehl, A. M., D. C. Johns, S. Yang, H. Lin, M. Yin, L. A. Matelis, and J. H. Lawrence. 1996. Adenovirus-mediated transfer of CCAAT/enhancer-binding protein-α identifies a dominant antiproliferative role for this isoform in hepatocytes. J. Biol. Chem. 271:7343-7350.
12. Dumaz, N., and D. W. Meek. 1999. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 18:7002-7010.
13. Fornace, A. J., Jr., D. W. Nebert, M. C. Hollander, J. D. Luethy, M. Papathanasiou, J. Fargnoli, and N. J. Holbrook. 1989. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol. 9:4196-4203.
14. Freytag, S. O., D. L. Paielli, and J. D. Gilbert. 1994. Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 8:1654-1663.
15. Gailani, M. R., D. J. Leffell, A. Ziegler, E. G. Gross, D. E. Brash, and A. E. Bale. 1996. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J. Natl. Cancer Inst. 88:349-354.
16. Garmyn, M., M. Yaar, N. Holbrook, and B. A. Gilchrest. 1991. Immediate and delayed molecular response of human keratinocytes to solar-simulated irradiation. Lab. Investig. 65:471-478.
17. Halmos, B., C. S. Huettner, O. Kocher, K. Ferenczi, D. D. Karp, and D. G. Tenen. 2002. Down-regulation and antiproliferative role of C/EBPα in lung cancer. Cancer Res. 62:528-534.
18. Harris, T. E., J. H. Albrecht, M. Nakanishi, and G. J. Darlington. 2001. CCAAT/enhancer-binding protein-α cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding. J. Biol. Chem. 276:29200-29209.
19. Hennings, H., D. Michael, C. Cheng, P. Steinert, K. Holbrook, and S. H. Yuspa. 1980. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-254.
20. Hulla, J. E., J. E. French, and J. K. Dunnick. 2001. Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice. Carcinogenesis 22:89-98.
21. Jonason, A. S., S. Kunala, G. J. Price, R. J. Restifo, H. M. Spinelli, J. A. Persing, D. J. Leffell, R. E. Tarone, and D. E. Brash. 1996. Frequent clones of p53 keratinocytes in normal human skin. Proc. Natl. Acad. Sci. USA 93:14025-14029.
22. Kubicka, S., F. Kuhnel, L. Zender, K. L. Rudolph, J. Plumpe, M. Manns, and C. Trautwein. 1999. p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesis. J. Biol. Chem. 274:32137-32144.
23. Lee, Y. H., B. Sauer, P. F. Johnson, and F. J. Gonzalez. 1997. Disruption of the c/ebpα gene in adult mouse liver. Mol. Cell. Biol. 17:6014-6022.
24. Lehman, T. A., R. Modali, P. Boukamp, J. Stanek, W. P. Bennett, J. A. Welsh, R. A. Metcalf, M. R. Stampfer, N. Fusenig, E. M. Rogan, et al. 1993. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14:833-839.
25. Lin, F. T., and M. D. Lane. 1994. CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc. Natl. Acad. Sci. USA 91:8757-8761.
26. Margulies, L., and P. B. Sehgal. 1993. Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBP beta (NF-IL6) activity by p53 species. J. Biol. Chem. 268:15096-15100.
27. Maytin, E. V., and J. F. Habener. 1998. Transcription factors C/EBPα, C/EBPβ, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vivo and in vitro. J. Investig. Dermatol. 110:238-246.
28. Medrano, E. E., S. Im, F. Yang, and Z. A. Abdel-Malek. 1995. Ultraviolet B light induces G1 arrest in human melanocytes by prolonged inhibition of retinoblastoma protein phosphorylation associated with long-term expression of the p21Waf-1/SD1-1/Cip-1 protein. Cancer Res. 55:4047-4052.
29. Miller, D. L., and M. A. Weinstock. 1994. Nonmelanoma skin cancer in the United States: incidence. J. Am. Acad. Dermatol. 30:774-778.
30. Muller, C., M. Alunni-Fabbroni, E. Kowenz-Leutz, X. Mo, M. Tommasino, and A. Leutz. 1999. Separation of C/EBPα-mediated proliferation arrest and differentiation pathways. Proc. Natl. Acad. Sci. USA 96:7276-7281.
31. Muller, C., C. F. Calkhoven, X. Sha, and A. Leutz. 2004. The CCAAT enhancer-binding protein alpha (C/EBPα) requires a SWI/SNF complex for proliferation arrest. J. Biol. Chem. 279:7353-7358.
32. Neades, R., L. Cox, and J. C. Pelling. 1998. S-phase arrest in mouse keratinocytes exposed to multiple doses of ultraviolet B/A radiation. Mol. Carcinog. 23:159-167.
33. Oh, H.-S., and R. C. Smart. 1998. Expression of CCAAT/enhancer binding protein (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms. J. Investig. Dermatol. 110:939-945.
34. O'Rourke, J., R. Yuan, and J. DeWille. 1997. CCAAT/enhancer-binding protein-delta (C/EBP-δ) is induced in growth-arrested mouse mammary epithelial cells. J. Biol. Chem. 272:6291-6296.
35. Pabst, T., B. U. Mueller, P. Zhang, H. S. Radomska, S. Narravula, S. Schnittger, G. Behre, W. Hiddemann, and D. G. Tenen. 2001. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia. Nat. Genet. 27:263-270.
36. Park, D. S., E. J. Morris, L. A. Greene, and H. M. Geller. 1997. G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J. Neurosci. 17:1256-1270.
37. Piontkewitz, Y., S. Enerback, and L. Hedin. 1993. Expression and hormonal regulation of the CCAAT enhancer binding protein-alpha during differentiation of rat ovarian follicles. Endocrinology 133:2327-2333.
38. Porse, B. T., T. A. Pedersen, X. Xu, B. Lindberg, U. M. Wewer, L. Friis-Hansen, and C. Nerlov. 2001. E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo. Cell 107:247-258.
39. Radomska, H. S., C. S. Huettner, P. Zhang, T. Cheng, D. T. Scadden, and D. G. Tenen. 1998. CCAAT/enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol. Cell. Biol. 18:4301-4314.
40. Ramji, D. P., and P. Foka. 2002. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365:561-575.
41. Saito, S., H. Yamaguchi, Y. Higashimoto, C. Chao, Y. Xu, A. J. Fornace, Jr., E. Appella, and C. W. Anderson. 2003. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. 278:37536-37544.
42. Sarkaria, J. N., E. C. Bushy, R. S. Tihhetts, P. Roos, Y. Taya, L. M. Karnitz, and R. T. Abraham. 1999. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59:4375-4382.
43. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 17:6419.
44. Scott, L. M., C. I. Civin, P. Roth, and A. D. Friedman. 1992. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80:1725-1735.
45. Shieh, S. Y., M. Ikeda, Y. Taya, and C. Prives. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325-334.
46. Slomiany, B. A., K. L. D'Arigo, M. M. Kelly, and D. T. Kurtz. 2000. C/EBPα inhibits cell growth via direct repression of E2F-DP-mediated transcription. Mol. Cell. Biol. 20:5986-5997.
47. Swart, G. W. M., J. J. M. van Groningen, F. van Ruissen, M. Bergers, and J. Schalkwijk. 1997. Transcription factor C/EBPα: novel sites of expression and cloning of the human gene. Biol. Chem. 378:373-379.
48. Tibbetts, R. S., K. M. Brumbaugh, J. M. Williams, J. N. Sarkaria, W. A. Cliby, S. Y. Shieh, Y. Taya, C. Prives, and R. T. Abraham. 1999. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13:152-157.
49. Timchenko, N. A., M. Wilde, and G. J. Darlington. 1999. C/EBPα regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice. Mol. Cell. Biol. 19:2936-2945.
50. Timchenko, N. A., M. Wilde, P. Iakova, J. H. Albrecht, and G. J. Darlington. 1999. E2F/107 and E2F/p130 complexes are regulated by C/EBPα in 3T3-L1 adipocytes. Nucleic Acids Res. 27:3621-3630.
51. Timchenko, N. A., M. Wilde, M. Nakanishi, J. R. Smith, and G. J. Darlington. 1996. CCAAT/enhancer-binding protein alpha (C/EBPα) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev. 10:804-815.
52. Umek, R. M., A. D. Friedman, and S. L. McKnight. 1991. CCAAT-enhancer binding protein: a component of a differentiation switch. Science 251:288-292.
53. Vincent, F., G. Deplanque, J. Ceraline, B. Duclos, and J. P. Bergerat. 1999. p53-independent regulation of cyclin B1 in normal human fibroblasts during UV-induced G2-arrest. Biol. Cell 91:665-674.
54. Waldman, T., K. W. Kinzler, and B. Vogelstein. 1995. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55:5187-5190.
55. Wang, H., P. Iakova, M. Wilde, A. Welm, T. Goode, W. J. Roesler, and N. A. Timchenko. 2001. C/EBPα arrests cell proliferation through direct inhibition of cdk2 and cdk4. Mol. Cell 8:817-828.
56. Wang, X., E. Scott, C. L. Sawyers, and A. D. Friedman. 1999. C/EBPα bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D c13 myeloblasts. Blood 94:560-571.
57. Wang, X. W., Q. Zhan, J. D. Coursen, M. A. Khan, H. U. Kontny, L. Yu, M. C. Hollander, P. M. O'Connor, A. J. Fornace, Jr., and C. C. Harris. 1999. GADD45 induction of a G2/M cell cycle checkpoint. Proc. Natl. Acad. Sci. USA 96:3706-3711.
58. Wang, X. Z., B. Lawson, J. W. Brewer, H. Zinszner, A. Sanjay, L. J. Mi, R. Boorstein, G. Kreibich, L. M. Hendershot, and D. Ron. 1996. Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153). Mol. Cell. Biol. 16:4273-4280.
59. Westendorf, J. J., C. M. Yamamoto, N. Lenny, J. R. Downing, M. E. Selsted, and S. W. Hiebert. 1998. The t(8;21) fusion protein, AML-1-ETO, associated with C/EBP-α, inhibits C/EBP-α-dependent transcription and blocks granulocytic differentiation. Mol. Cell. Biol. 18:322-333.
60. Xu, L., L. Hui, S. Wang, J. Gong, Y. Jin, Y. Wang, Y. Ji, X. Wu, Z. Han, and G. Hu. 2001. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res. 61:3176-3181.
61. Zhu, S., H. S. Oh, M. Sbim, E. Sterneck, P. F. Johnson, and R. C. Smart. 1999. C/EBPβ modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression. Mol. Cell. Biol. 19:7181-7190.
62. Zhu, S., K. Yoon, E. Sterneck, P. F. Johnson, and R. C. Smart. 2002. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc. Natl. Acad. Sci. USA 99:207-212.
63. Ziegler, A., A. S. Jonason, D. J. Leffell, J. A. Simon, H. W. Sharma, J. Kimmelman, L. Remington, T. Jacks, and D. E. Brash. 1994. Sunburn and p53 in the onset of skin cancer. Nature 372:773-776.